De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors

Highlights • EGFR mutations occur in some high-grade neuroendocrine lung cancers. • EGFR protein is not expressed in EGFR mutated neuroendocrine lung cancers. • Patients with neuroendocrine lung cancers don’t respond to EGFR inhibitors.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2015-04, Vol.88 (1), p.70-73
Hauptverfasser: Le, Xiuning, Desai, Neelam V, Majid, Adnan, Karp, Rebecca S, Huberman, Mark S, Rangachari, Deepa, Kent, Michael S, Gangadharan, Sidharta P, Folch, Erik, VanderLaan, Paul A, Costa, Daniel B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • EGFR mutations occur in some high-grade neuroendocrine lung cancers. • EGFR protein is not expressed in EGFR mutated neuroendocrine lung cancers. • Patients with neuroendocrine lung cancers don’t respond to EGFR inhibitors.
ISSN:0169-5002
1872-8332
DOI:10.1016/j.lungcan.2015.02.003